| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C9H15NO3S
|
|---|
| Exact mass |
217.0773
|
|---|
| Mol weight |
217.29
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09A ACE INHIBITORS, PLAIN
C09AA ACE inhibitors, plain
C09AA01 Captopril
D00251 Captopril (JP19/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Angiotensin-converting Enzyme (ACE) Inhibitors
Captopril
D00251 Captopril (JP19/USP/INN)
Kidney Agents
Angiotensin-converting Enzyme (ACE) Inhibitors
Captopril
D00251 Captopril (JP19/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2144 Angiotensin converting enzyme inhibitors
D00251 Captopril (JP19/USP/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01501 Angiotensin-converting enzyme inhibitor
D00251 Captopril
DG03231 Antihypertensive
DG01501 Angiotensin-converting enzyme inhibitor
D00251 Captopril
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Metallo peptidases
Family M2
ACE (CD143)
D00251 Captopril (JP19/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00251 Captopril
Prodrugs [br08324.html]
D00251
Prodrugs [br08324.html]
C06867
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 14
1 C1x C 13.2542 -17.7957
2 C1x C 13.6644 -19.2026
3 C1x C 15.0626 -19.1554
4 C1y C 15.5164 -17.8328
5 N1y N 14.3987 -16.9924
6 C5a C 14.3987 -15.5941
7 O5a O 15.6046 -14.8978
8 C1c C 13.1687 -14.8841
9 C1b C 11.9793 -15.5711
10 S1a S 10.7909 -14.8851
11 C6a C 16.8442 -17.4251
12 O6a O 18.1954 -18.0070
13 O6a O 16.8835 -16.0376
14 C1a C 13.1684 -13.4806
BOND 14
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 5 6 1
7 6 7 2
8 6 8 1
9 8 9 1
10 9 10 1
11 4 11 1 #Down
12 11 12 1
13 11 13 2
14 8 14 1 #Up
|
|---|
